Bernd Sido
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adrenal insufficiency is a contraindication for omalizumab therapy in mast cell activation disease: risk for serum sickness.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 31, 2020
Surgical interventions in patients with systemic mast cell activation disease : Recommendations for perioperative management
Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
Published: March 16, 2019
Endoscopic full-thickness resection using an over-the-scope device for treatment of recurrent / residual colorectal neoplasia: a single-center case series.
Journal: BMC gastroenterology
Published: February 17, 2019
Implementation of endoscopic submucosal dissection for early upper gastrointestinal tract cancer after primary experience in colorectal endoscopic submucosal dissection.
Journal: Endoscopy international open
Published: August 11, 2018
Full-thickness resection with an over-the-scope device: possible translocation of adenoma tissue in a case of an incomplete resection at the appendix.
Journal: Endoscopy international open
Published: November 03, 2017
Endoscopic submucosal dissection for flat or sessile colorectal neoplasia > 20 mm: A European single-center series of 182 cases.
Journal: Endoscopy international open
Published: February 27, 2016
Endoscopic mucosal resection of colorectal adenomas > 20 mm: Risk factors for recurrence.
Journal: World journal of gastrointestinal endoscopy
Published: August 16, 2015
Endoscopic Submucosal Dissection (ESD) in Colorectal Tumors.
Journal: Viszeralmedizin
Published: February 01, 2014
Surgical interventions in patients with mast cell activation disease. Aspects relevant for surgery using the example of a cholecystectomy
Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
Published: December 17, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026